Hyponatremia and Outcome: Is Severity More Important Than Etiology?
euvolemic
hypervolemic
hypotonic
metabolic abnormalities
metabolic disease
mortality
profound hyponatremia
siadh
symptomatic hyponatremia
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
01
08
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Hyponatremia is the most common electrolyte abnormality encountered in a hospital setting, and the data regarding the contribution of hyponatremia to overall mortality are conflicting. The study objective was to determine patients' clinical profiles and outcomes with hyponatremia. This prospective cross-sectional study was conducted at Dayanand Medical College and Hospital, Ludhiana, and included 375 adult patients aged more than 18 years with a confirmed diagnosis of hyponatremia. Patients were subdivided into three groups based on the severity of hyponatremia: mild (130-135 mmol/L), moderate (125-129 mmol/L), and profound (<125 mmol/L). The most common symptom was confusion (57.3%) followed by deep somnolence (40%) and nausea (36.8%). The most common cause of hyponatremia was diuretics (30.7%), followed by the syndrome of inappropriate antidiuretic hormone secretion (SIADH) (17.8%) and chronic liver disease (CLD) (14.1%). The severity of hyponatremia did not significantly influence the outcome. Patients with CLD and chronic kidney disease (CKD) as the etiology of hyponatremia had significantly worse outcomes compared to other causes of hyponatremia. The most common type was hypovolemic hypotonic followed by euvolemic hypotonic and hypervolemia hypotonic hyponatremia. Nearly half of the total deaths were observed in the hypervolemic hyponatremia group and were significantly higher compared to the other two groups (p=0.001). Correction of hyponatremia (i.e., serum sodium >135 mmol/L) was significantly linked with good outcomes (p=0.003). Our study showed that the etiology of hyponatremia was a more important prognostic indicator rather than the severity of hyponatremia. Normalization of serum sodium was associated with improved survival.
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
Hyponatremia is the most common electrolyte abnormality encountered in a hospital setting, and the data regarding the contribution of hyponatremia to overall mortality are conflicting. The study objective was to determine patients' clinical profiles and outcomes with hyponatremia.
METHODS
METHODS
This prospective cross-sectional study was conducted at Dayanand Medical College and Hospital, Ludhiana, and included 375 adult patients aged more than 18 years with a confirmed diagnosis of hyponatremia. Patients were subdivided into three groups based on the severity of hyponatremia: mild (130-135 mmol/L), moderate (125-129 mmol/L), and profound (<125 mmol/L).
RESULTS
RESULTS
The most common symptom was confusion (57.3%) followed by deep somnolence (40%) and nausea (36.8%). The most common cause of hyponatremia was diuretics (30.7%), followed by the syndrome of inappropriate antidiuretic hormone secretion (SIADH) (17.8%) and chronic liver disease (CLD) (14.1%). The severity of hyponatremia did not significantly influence the outcome. Patients with CLD and chronic kidney disease (CKD) as the etiology of hyponatremia had significantly worse outcomes compared to other causes of hyponatremia. The most common type was hypovolemic hypotonic followed by euvolemic hypotonic and hypervolemia hypotonic hyponatremia. Nearly half of the total deaths were observed in the hypervolemic hyponatremia group and were significantly higher compared to the other two groups (p=0.001). Correction of hyponatremia (i.e., serum sodium >135 mmol/L) was significantly linked with good outcomes (p=0.003).
CONCLUSION
CONCLUSIONS
Our study showed that the etiology of hyponatremia was a more important prognostic indicator rather than the severity of hyponatremia. Normalization of serum sodium was associated with improved survival.
Identifiants
pubmed: 37664323
doi: 10.7759/cureus.42808
pmc: PMC10470662
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e42808Informations de copyright
Copyright © 2023, Singh et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Curr Med Res Opin. 2008 Jun;24(6):1601-8
pubmed: 18426691
Clin Endocrinol (Oxf). 2006 Aug;65(2):246-9
pubmed: 16886968
QJM. 2009 Mar;102(3):175-82
pubmed: 19106156
Indian J Med Res. 2011 Jul;134:118-22
pubmed: 21808144
Br J Clin Pharmacol. 2006 Jan;61(1):87-95
pubmed: 16390355
Am J Med. 2013 Oct;126(10 Suppl 1):S1-42
pubmed: 24074529
J Am Geriatr Soc. 2010 Nov;58(11):2227-8
pubmed: 21054304
Front Horm Res. 2019;52:24-35
pubmed: 32097911
PLoS One. 2015 Apr 23;10(4):e0124105
pubmed: 25905459
Eur J Intern Med. 2014 Apr;25(4):379-82
pubmed: 24582329
Am J Med. 2009 Sep;122(9):857-65
pubmed: 19699382
Indian J Endocrinol Metab. 2012 Mar;16(2):288-91
pubmed: 22470870
Ann Intern Med. 1987 Nov;107(5):656-64
pubmed: 3662278
J Clin Invest. 1958 Sep;37(9):1236-56
pubmed: 13575523
QJM. 2006 Aug;99(8):505-11
pubmed: 16861720
Indian J Crit Care Med. 2017 Dec;21(12):819-824
pubmed: 29307961
Internist (Berl). 2015 Jul;56(7):753-9
pubmed: 26036654
Clin J Am Soc Nephrol. 2011 May;6(5):960-5
pubmed: 21441132
Am J Med. 2006 Jul;119(7 Suppl 1):S30-5
pubmed: 16843082
J Assoc Physicians India. 2018 May;66(5):48-52
pubmed: 30477055
Indian J Endocrinol Metab. 2014 Nov;18(6):760-71
pubmed: 25364669
Cent Afr J Med. 1998 Jun;44(6):154-8
pubmed: 9810397
J Gen Intern Med. 1986 Nov-Dec;1(6):380-5
pubmed: 3794837
Indian J Crit Care Med. 2014 Feb;18(2):83-7
pubmed: 24678150
Nephrol Dial Transplant. 2014 Apr;29 Suppl 2:i1-i39
pubmed: 24569496
PLoS One. 2014 Feb 05;9(2):e88272
pubmed: 24505459
J Gen Intern Med. 1994 Feb;9(2):89-91
pubmed: 8164083
J Assoc Physicians India. 2010 Nov;58:667-9
pubmed: 21510458